In previous studies, GIHCG was found to be highly expressed in a variety of tumors and to promote the development of hepatocellular carcinoma, esophageal carcinoma, renal cell carcinoma and other tumors through different pathways21–23. This evidence concerns the gene GIHCG and renal cell carcinoma.